Y Intercept (Hong Kong) LTD Crispr Therapeutics Ag Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $409,503 - $582,074	-3,716 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$100.84 - $161.89 $374,721 - $601,583	3,716 New	3,716 $602,000
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $751,056 - $1.21 Million	-7,448 Closed	0 $602,000
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $824,642 - $1.56 Million	7,448 New	7,448 $858,000

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.69B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.